Cerebral Angiography Market is estimated to be valued at USD 17.90 Bn in 2026 and is expected to reach USD 27.45 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.3% from 2026 to 2033.
| Report Coverage |
Report Details |
| Base Year: |
2025 |
Market Size in 2026: |
USD 17.90 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: |
6.30% |
2033 Value Projection: |
USD 27.45 Bn |
The global cerebral angiography market covers a broad set of procedure type categories, including Diagnostic Cerebral Angiography, and Therapeutic Cerebral Angiography, used across applications such as Neurology, Neurosurgery, and Interventional Radiology. Demand is supported by adoption among Hospitals, and Diagnostic Imaging Centers and the need for more efficient, reliable solutions. Continued technological advancement and rising end-user requirements are shaping the growth of this market.
Market Dynamics:
Growing adoption across Neurology, and Neurosurgery, rising end-user demand, and a continued focus on improving efficiency and performance are major factors expected to drive growth of the global cerebral angiography market. A wider range of available options is making these solutions accessible to a broader base of users.
For instance, companies are expanding their portfolios to address evolving requirements across Hospitals, and Diagnostic Imaging Centers. Moreover, increasing investment in innovation and new technology integration is expected to create new growth opportunities for market players over the forecast period.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global cerebral angiography market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems Corporation, Shimadzu Corporation, Medtronic plc, Stryker Corporation, Terumo Corporation, Boston Scientific Corporation, AngioDynamics, Inc., Penumbra, Inc., MicroPort Scientific Corporation, and Cook Medical LLC and Cordis, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global cerebral angiography market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cerebral angiography market.
Detailed Segmentation:
- Global Cerebral Angiography Market, By Procedure Type (Revenue, USD Bn, 2021 - 2033)
- Diagnostic Cerebral Angiography
- Therapeutic Cerebral Angiography
- Global Cerebral Angiography Market, By Imaging Technique (Revenue, USD Bn, 2021 - 2033)
- Digital Subtraction Angiography (DSA)
- Magnetic Resonance Angiography (MRA)
- Computed Tomography Angiography (CTA)
- Catheter Angiography
- Intraoperative Angiography
- Other advanced imaging
- techniques
- Global Cerebral Angiography Market, By Indication (Revenue, USD Bn, 2021 - 2033)
- Intracranial Aneurysms
- Arteriovenous Malformations (AVMs)
- Stroke
- Cerebral Tumors
- Cerebrovascular Disease
- Others
- Global Cerebral Angiography Market, By End-User (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- Academic and Research Institutions
- Global Cerebral Angiography Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
- Angiography Systems
- Catheters
- Guidewires
- Contrast Media
- Accessories and Consumables
- Global Cerebral Angiography Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Neurology
- Neurosurgery
- Interventional Radiology
- Others
- Global Cerebral Angiography Market, By Patient Age (Revenue, USD Bn, 2021 - 2033)
- Adult Patients
- Pediatric Patients
- Global Cerebral Angiography Market, By Imaging Modality (Revenue, USD Bn, 2021 - 2033)
- X-ray-based Angiography
- Magnetic Resonance Imaging (MRI)-based Angiography
- Computed Tomography (CT)-based Angiography
- Global Cerebral Angiography Market, By Procedure Setting (Revenue, USD Bn, 2021 - 2033)
- Conventional Angiography Suite
- Interventional Radiology Suite
- Operating Room
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- Siemens Healthineers AG*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- GE Healthcare
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- Shimadzu Corporation
- Medtronic plc
- Stryker Corporation
- Terumo Corporation
- Boston Scientific Corporation
- AngioDynamics, Inc.
- Penumbra, Inc.
- MicroPort Scientific Corporation
- Cook Medical LLC and Cordis
"*" marked represents similar segmentation in other categories in the respective section.